What We Do
New Amsterdam Sciences develops novel, safe and effective therapies for persistent inflammatory conditions specifically oxidative stress (ROS) driven inflammation, with an initial focus on Rheumatoid Arthritis, Infectious Disease and CNS disorders
InfluenzaDeveloping targeted therapies and adjuvants for influenza which have demonstrated greater efficacy than Tamiflu, the current “gold standard.”
Progressive Supranuclear PalsyDeveloping first-in-line therapies for orphan neurodegenerative disorders like Progressive Supranuclear Palsy (PSP).
RadiomitigatorsDeveloping radiation mitigators to treat the difficult side effects that can occur from undergoing radiation therapy for cancer, as well as biodefense applications.
Narrow focus, open mindsThrough the company's anti-inflammatory platform and it's family of therapeutics, NAS pursues novel treatments to enhance the lives of patients in multiple areas of development. Other Areas of Interest
Covid Hot Spots